$72.8 M

SSKN Mkt cap, 21-May-2019

$7.9 M

STRATA Skin Sciences Revenue Q3, 2018
STRATA Skin Sciences Gross profit (Q3, 2018)4.8 M
STRATA Skin Sciences Gross profit margin (Q3, 2018), %61.4%
STRATA Skin Sciences Net income (Q3, 2018)-290 K
STRATA Skin Sciences Cash, 30-Sep-201815.9 M
STRATA Skin Sciences EV64.3 M

STRATA Skin Sciences Revenue

STRATA Skin Sciences revenue was $31.45 m in FY, 2017

Embed Graph

STRATA Skin Sciences Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

536.0k915.0k18.5m31.8m31.4m

Revenue growth, %

71%1921%72%

Cost of goods sold

4.3m4.9m13.7m12.6m13.5m

Gross profit

(3.8m)(4.0m)4.8m19.1m18.0m

Gross profit Margin, %

(710%)(439%)26%60%57%

Sales and marketing expense

9.2m13.2m11.2m

R&D expense

3.8m1.6m2.0m1.9m1.7m

General and administrative expense

15.5m11.0m10.0m7.6m7.4m

Operating expense total

20.3m12.6m21.3m22.7m20.4m

EBIT

(24.1m)(16.6m)(16.5m)(2.4m)

EBIT margin, %

(4503%)(1817%)(89%)(8%)

Interest expense

564.0k2.4m10.2m4.9m4.6m

Interest income

8.0k8.0k

Pre tax profit

(24.8m)(3.1m)(18.7m)

Income tax expense

119.0k255.0k129.0k

Net Income

(25.9m)(14.1m)(24.9m)(3.3m)(18.8m)

STRATA Skin Sciences Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

3.8m11.4m3.3m3.9m4.1m

Accounts Receivable

57.0k220.0k4.1m3.4m3.1m

Inventories

5.6m274.0k4.1m2.8m3.0m

Current Assets

10.4m17.2m12.0m10.8m10.8m

PP&E

3.7m2.0m13.9m10.2m7.7m

Goodwill

8.9m8.8m8.8m

Total Assets

14.1m20.1m51.4m43.2m38.6m

Accounts Payable

1.5m1.2m4.4m1.9m2.3m

Short-term debt

299.0k1.7m2.4m

Current Liabilities

5.7m2.7m7.1m6.1m7.7m

Long-term debt

10.2m7.9m

Total Debt

10.5m1.7m10.2m

Total Liabilities

5.8m35.3m28.5m16.4m

Additional Paid-in Capital

176.4m194.6m223.3m225.3m251.6m

Retained Earnings

(168.1m)(182.3m)(207.2m)(210.6m)(229.4m)

Total Equity

8.3m12.3m16.1m14.7m22.2m

Debt to Equity Ratio

0.1 x

Debt to Assets Ratio

0 x

Financial Leverage

1.7 x1.6 x3.2 x2.9 x1.7 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

2.6m8.1m4.2m14.5m8.2m5.6m3.2m3.1m2.8m3.0m3.8m3.9m3.1m3.4m14.4m15.9m

Accounts Receivable

50.9k34.1k49.5k85.2k5.8k

Inventories

271.6k5.6m3.9m5.4m5.2m3.4m3.9m4.2m3.8m3.2m2.7m3.5m3.5m3.0m2.4m2.5m

Current Assets

3.6m14.3m8.5m20.5m13.9m13.4m12.0m10.9m9.6m9.4m10.5m11.4m10.1m10.3m20.3m21.8m

PP&E

9.4m3.0m3.9m2.7m1.6m14.8m14.5m12.8m11.6m10.8m10.0m9.4m8.7m6.9m6.3m5.7m

Goodwill

8.0m8.9m8.9m8.8m8.8m8.8m8.8m8.8m8.8m8.8m8.8m

Total Assets

13.1m17.4m12.5m24.3m16.2m54.4m52.2m47.5m44.4m43.0m43.2m42.9m39.9m36.8m45.7m46.2m

Accounts Payable

1.4m1.3m1.1m1.3m1.3m4.8m4.2m3.5m2.6m1.9m2.2m2.3m1.9m2.7m1.5m1.7m

Short-term debt

54.0k39.0k195.0k93.0k857.0k2.6m3.4m1.9m3.4m

Current Liabilities

2.6m10.9m5.2m4.0m3.9m16.6m15.3m5.6m4.4m4.6m7.6m8.4m6.1m9.0m4.3m4.8m

Long-term debt

11.3m11.3m10.5m8.9m8.2m8.8m6.9m7.3m7.4m

Non-Current Liabilities

114.9k5.1m

Total Debt

54.0k39.0k11.5m11.4m11.4m11.5m11.6m10.8m10.3m7.3m7.4m

Total Liabilities

2.9m11.0m5.3m9.1m27.2m36.3m32.5m27.1m27.1m30.6m31.3m15.9m16.9m12.4m12.8m

Additional Paid-in Capital

173.8m182.4m182.6m193.0m197.1m224.6m222.5m223.7m225.4m225.6m225.4m225.6m251.6m251.7m266.5m266.9m

Retained Earnings

(163.5m)(176.1m)(175.5m)(177.8m)(189.6m)(197.4m)(206.6m)(208.7m)(208.2m)(209.7m)(212.8m)(214.0m)(227.7m)(231.9m)(233.2m)(233.5m)

Total Equity

6.4m7.1m15.2m7.5m27.3m15.9m15.0m17.3m15.9m12.6m11.6m23.9m19.8m33.3m33.4m

Debt to Equity Ratio

0.5 x0.2 x

Debt to Assets Ratio

0.3 x0.2 x

Financial Leverage

2.7 x1.7 x1.6 x2.2 x2 x3.3 x3.2 x2.6 x2.7 x3.4 x3.7 x1.7 x1.9 x1.4 x1.4 x

STRATA Skin Sciences Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(25.9m)(14.1m)(24.9m)(3.3m)(18.8m)

Depreciation and Amortization

2.4m1.8m4.1m6.4m6.3m

Accounts Receivable

77.0k(215.0k)(186.0k)558.0k184.0k

Inventories

121.0k606.0k(508.0k)1.3m(193.0k)

Accounts Payable

(484.0k)(241.0k)542.0k(2.6m)381.0k

Cash From Operating Activities

(19.4m)(17.7m)(6.6m)322.0k4.1m

Purchases of PP&E

(5.2m)(320.0k)

Cash From Investing Activities

(5.2m)17.0k(44.2m)(868.0k)(2.2m)

Long-term Borrowings

(93.0k)(333.0k)(1.4m)

Cash From Financing Activities

20.5m25.3m42.7m1.2m(1.8m)

Interest Paid

116.0k1.2m2.1m2.2m

Income Taxes Paid

28.0k

STRATA Skin Sciences Ratios

USDY, 2018

EV/CFO

35.8 x

Financial Leverage

1.4 x

STRATA Skin Sciences Employee Rating

2.86 votes
Culture & Values
2.3
Work/Life Balance
2.5
Senior Management
2.7
Salary & Benefits
2.3
Career Opportunities
2.3
Source